91ɫƵ

header-logo
Physician Patient
Eric Larson, PhD, ABPP-CN

Eric R. Larson, PhD, ABPP-CN

Associate Professor

Locations

  • 91ɫƵ
    Department of Psychiatry and Behavioral Medicine

Contact Information

Biography

Dr. Larson is a board certified clinical neuropsychologist whose clinical practice takes place at the Clement J. Zablocki VA Medical Center and the 91ɫƵ Tosa Center. Dr. Larson is active in medical school, psychiatry residency, clinical psychology, and clinical neuropsychology education.

Dr. Larson completed his undergraduate training at Indiana University and his graduate training at the University of Cincinnati. He then completed a fellowship in clinical neuropsychology through 91ɫƵ’s Department of Neurology where he received the David Fine, MD Award for Excellence in Post Graduate Training. Prior to joining the 91ɫƵ faculty, Dr. Larson served as Assistant Professor of Psychiatry and Behavioral Sciences at the University of Chicago.

Research Interests

Dr. Larson's primary clinical interests include neuropsychological assessment of adult patients with:

Suspected dementia
Traumatic brain injury
Stroke
Suspected attention deficit hyperactivity disorder (ADHD)

Dr. Larson's primary research interests include:

How a person's ability to recognize, or fail to recognize, his or her own cognitive strengths and weaknesses can change during periods of psychiatric decompensation and with neurological disease
Cognitive dysfunction associated with Parkinson’s disease
How social functioning changes in various dementing conditions
The interaction between cognition and symptoms of post-traumatic stress disorder

Dr. Larson also has forensic interests related to:

Decisionality
Informed consent
Traumatic brain injury
Post-traumatic stress disorder

Publications

  • (Harfmann EJ, McAuliffe TL, Larson ER, Claesges SA, Sauber G, Hillard CJ, Goveas JS.) Psychoneuroendocrinology. 2020 Oct;120:104801 PMID: 32682172 PMCID: PMC7348598 SCOPUS ID: 2-s2.0-85087803094 07/19/2020

  • (Larsen SE, Larson ER, Hunt JC, Lorber WG, deRoon-Cassini TA.) Mil Med. 2020 Jan 07;185(Suppl 1):161-167 PMID: 31498405 SCOPUS ID: 2-s2.0-85080846211 09/10/2019

  • (Pezzin LE, Larson ER, Lorber W, McGinley EL, Dillingham TR.) BMC Psychol. 2018 Dec 19;6(1):60 PMID: 30567598 PMCID: PMC6299962 SCOPUS ID: 2-s2.0-85058871441 12/21/2018

  • (Considine CM, Parker HA, Briggs J, Quasney EE, Larson ER, Smith H, Shollenbarger SG, Abeare CA.) J Int Neuropsychol Soc. 2018 Sep;24(8):864-875 PMID: 30189910 SCOPUS ID: 2-s2.0-85053128951 09/08/2018

  • (Hlubocky FJ, Sachs GA, Larson ER, Nimeiri HS, Cella D, Wroblewski KE, Ratain MJ, Peppercorn JM, Daugherty CK.) J Clin Oncol. 2018 Aug 20;36(24):2483-2491 PMID: 29985748 PMCID: PMC6097830 07/10/2018

  • (Larson ER.) Clin Neuropsychol. 2015;29(1):166-78 PMID: 25658417 02/07/2015

  • (Larson ER, Shear PK, Krikorian R, Welge J, Strakowski SM.) J Int Neuropsychol Soc. 2005 Mar;11(2):163-72 PMID: 15962704 06/21/2005

  • (Strakowski SM, DelBello MP, Sax KW, Zimmerman ME, Shear PK, Hawkins JM, Larson ER.) Arch Gen Psychiatry. 1999 Mar;56(3):254-60 PMID: 10078503 03/17/1999

  • (Sax KW, Strakowski SM, Keck PE Jr, McElroy SL, West SA, Bourne ML, Larson ER.) Am J Psychiatry. 1997 Sep;154(9):1299-301 PMID: 9286193 09/01/1997

  • (Ariano MA, Larson ER, Noblett KL, Sibley DR, Levine MS.) Synapse. 1997 Aug;26(4):400-14 PMID: 9215599 08/01/1997

  • (Ariano MA, Wang J, Noblett KL, Larson ER, Sibley DR.) Brain Res. 1997 Mar 28;752(1-2):26-34 PMID: 9106437 03/28/1997

  • (Ariano MA, Wang J, Noblett KL, Larson ER, Sibley DR.) Brain Res. 1997 Jan 23;746(1-2):141-50 PMID: 9037493 01/23/1997